SEC Form 4
Precision BioSciences, Inc. (DTIL) insider trading
In the 12 months to Oct 26, 2026, 3 DTIL insiders reported open-market purchases of $63.2K across 6 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $63.2K
- 6 filings
Who traded DTIL, and when
- Purchase
DTIL daily close from Oct 27, 2025 to Oct 26, 2026, between $3.57 and $9.28, last $6.40. 0 sale and 6 purchase filings by 3 insiders, marked at their filing dates. Geno J. Germano, Director: bought $30.5K across 2 filings, first filed Dec 17, 2025, last Sep 29, 2026. Stanley Frankel, Director: bought $18.7K across 2 filings, first filed Dec 17, 2025, last Sep 30, 2026. Melinda Brown, Director: bought $14.0K across 2 filings, first filed Dec 17, 2025, last Sep 29, 2026.
Largest mark · tap a row for others
Geno J. Germano · Director
Purchase $16,385
2,609 shares at $6.28 avg
Filed Sep 29, 2026 · traded Sep 25
Close on filing date $6.18
Geno J. Germano · Director
Director
$30.5K boughtStanley Frankel · Director
Director
$18.7K boughtMelinda Brown · Director
Director
$14.0K boughtOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Geno J. Germano | Director | — | $30.5K | 2 | — | |
| Stanley Frankel | Director | — | $18.7K | 2 | — | |
| Melinda Brown | Director | — | $14.0K | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Stanley Frankel Director | Purchase | 1,000 | $6.00 | $6.0K | 41,478 | |
traded | Geno J. Germano Director | Purchase | 2,609 | $6.28 | $16.4K | 47,492 | |
traded | Melinda Brown Director | Purchase | 1,135 | $6.27 | $7.1K | 45,481 | |
traded | Melinda Brown Director | Purchase | 1,381 | $4.97 | $6.9K | 23,346 | |
traded | Stanley Frankel Director | Purchase | 2,700 | $4.70 | $12.7K | 19,478 | |
traded | Geno J. Germano Director | Purchase | 3,000 | $4.72 | $14.2K | 23,883 |
GET /stocks/filings/vX/form-4?tickers=DTIL&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"DTIL"
],
"issuer_cik": "0001357874",
"owner_cik": "0001855726",
"accession_number": "0001628280-26-063980",
"form_type": "4",
"filing_date": "2026-09-30",
"period_of_report": "2026-09-28",
"issuer_name": "PRECISION BIOSCIENCES INC",
"issuer_trading_symbol": "DTIL",
"owner_name": "Frankel Stanley",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-28",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 1000,
"transaction_price_per_share": 6,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 41478,
"transaction_value": 6000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"DTIL"
],
"issuer_cik": "0001357874",
"owner_cik": "0001682988",
"accession_number": "0001628280-26-063767",
"form_type": "4",
"filing_date": "2026-09-29",
"period_of_report": "2026-09-25",
"issuer_name": "PRECISION BIOSCIENCES INC",
"issuer_trading_symbol": "DTIL",
"owner_name": "Brown Melinda",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-25",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 1135,
"transaction_price_per_share": 6.27,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 45481,
"transaction_value": 7116.45,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 35 records
- Option exercises24 records
- Tax withholding (sold to cover)11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Precision BioSciences, Inc.'s CEO sold stock?
No. Michael Amoroso (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is DTIL’s insider data?
These are DTIL Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track DTIL insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for DTIL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.